Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 994Neoplasms 852Carcinoma, Non-Small-Cell Lung 846Prostatic Neoplasms 529Neoplasm Metastasis 503Leukemia, Myeloid, Acute 489Melanoma 456Colorectal Neoplasms 448Multiple Myeloma 441Lung Neoplasms 422Pancreatic Neoplasms 353Recurrence 350Lymphoma 350Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 329Leukemia 324Leukemia, Lymphocytic, Chronic, B-Cell 302Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 245Carcinoma, Hepatocellular 234Glioblastoma 233Squamous Cell Carcinoma of Head and Neck 232Myelodysplastic Syndromes 231Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × Physician Education × Clear all
NCT02287025 2017-10-19

SMART

Bayer

Phase 4 Terminated
23 enrolled 6 charts

Physician Education

Data powered by HemOnc (CC BY 4.0) Colophon âš¡